Skip to main content
. Author manuscript; available in PMC: 2017 Feb 8.
Published in final edited form as: Nature. 2016 Aug 8;537(7619):229–233. doi: 10.1038/nature19339

Extended Data Table 2.

Enzyme inhibition IC50 values of bortezomib and GNF6702 on three proteolytic activities of wild type T. cruzi, PSMB4I29M T. cruzi, and H. sapiens proteasomes

GNF6702 IC50 [μM]* bortezomib IC50 [μM]*
wild type T. cruzi proteasome chymotrypsin 0.035 ± 0.0013 0.091 ± 0.0075
caspase >10 0.37 ± 0.012
trypsin >10 1.7 ± 0.088
PSMB4I29M T. cruzi proteasome chymotrypsin >10 0.26 ± 0.040
caspase >10 0.54 ± 0.012
trypsin >10 1.6 ± 0.058
H. sapiens constitutive proteasome chymotrypsin >10 0.030 ± 0.0070
caspase >10 0.16 ± 0.007
trypsin >10 7.9 ± 0.15
*

mean ± s.e.m.; n= 3 technical replicates